Company Filing History:
Years Active: 2017
Title: Innovations in Thyroid Tumor Classification by Eti Meiri
Introduction
Eti Meiri is an accomplished inventor based in Shoham, Israel. He has made significant contributions to the field of medical diagnostics, particularly in the classification of thyroid tumors. His innovative approach utilizes microRNA expression patterns to enhance the accuracy of tumor classification.
Latest Patents
Eti Meiri holds a patent for a groundbreaking invention titled "MiRNA expression signature in the classification of thyroid tumors." This patent presents a method for classifying thyroid tumors through the analysis of specific microRNA expression patterns in fine needle aspiration samples. The classification based on microRNA signatures allows for optimized diagnosis and treatment, as well as the determination of signature-specific therapy.
Career Highlights
Throughout his career, Eti Meiri has been associated with Rosetta Genomics Ltd., a company that focuses on developing innovative diagnostic solutions. His work has been pivotal in advancing the understanding of thyroid tumors and improving patient outcomes through tailored therapies.
Collaborations
Eti has collaborated with notable colleagues, including Gila Lithwick Yanai and Yael Spector, who have contributed to his research endeavors. Their combined expertise has furthered the development of diagnostic methods in the field of oncology.
Conclusion
Eti Meiri's innovative work in the classification of thyroid tumors through microRNA expression signatures represents a significant advancement in medical diagnostics. His contributions are paving the way for more effective and personalized treatment options for patients.